Pathology News
editor

About Editor

This author has not yet filled in any details.
So far Editor has created 833 blog entries.

August 2026

Integrated prostate cancer care: efficiency, accuracy, and confidence at every stage

2026-08-10T11:02:35+00:00

Prostate cancer is among the most diagnosed cancers in men, affecting approximately one in eight men during their lifetime.1 At the same time, prostate cancer is not a single disease but a broad spectrum of conditions with widely varying clinical behavior. Overstaging and understaging Diagnosing prostate cancer is not always straightforward. The key challenge lies in accurately [...]

Integrated prostate cancer care: efficiency, accuracy, and confidence at every stage2026-08-10T11:02:35+00:00

CurvReg: Curvature-aware registration for multi-stain alignment of liver biopsies

2026-08-10T08:12:29+00:00

The following abstract is drawn from a recently published paper in Journal of Pathology Informatics | ScienceDirect.com by Elsevier. We invite you to read the full paper and join the conversation, become a member of the Pathology News community to share your thoughts, ask questions, and engage with others around this work. Authors: Fatemeh Zabihollahya,b, [...]

CurvReg: Curvature-aware registration for multi-stain alignment of liver biopsies2026-08-10T08:12:29+00:00

Proscia Receives New FDA 510(k) Clearance for Concentriq AP-Dx with Predetermined Change Control Plan

2026-08-06T18:10:26+00:00

PHILADELPHIA — August 6, 2026 — Proscia® has received a new 510(k) clearance from the U.S. Food and Drug Administration (FDA) for Concentriq® AP-Dx. The clearance includes compatibility with the Leica Aperio® GT 450 DX slide scanner, cloud deployment, and a Predetermined Change Control Plan (PCCP). Concentriq AP-Dx is a digital pathology platform for primary diagnosis used [...]

Proscia Receives New FDA 510(k) Clearance for Concentriq AP-Dx with Predetermined Change Control Plan2026-08-06T18:10:26+00:00

Leeds NHS Innovation to Accelerate Global Adoption of AI-enabled Pathology for Cancer Diagnostics Through Epredia Partnership

2026-08-05T22:40:28+00:00

A pioneering pathology technology developed by Leeds Teaching Hospitals NHS Trust is set for international deployment after securing a commercial agreement with Epredia, a global leader in precision cancer diagnostics solutions. The technology, known as TANGO, is a world-first, laboratory quality tool developed by researchers at Leeds Teaching Hospitals’ National Pathology Imaging Co‑operative (NPIC). Many cancer diagnostic [...]

Leeds NHS Innovation to Accelerate Global Adoption of AI-enabled Pathology for Cancer Diagnostics Through Epredia Partnership2026-08-05T22:40:28+00:00

Unlocking Diagnostic Value at Fimlab with Aiforia® Breast Cancer Suite

2026-08-03T12:39:34+00:00

In modern clinical pathology, adopting artificial intelligence (AI) is no longer just about algorithm accuracy. A key success factor is seamless workflow integration. Pathology departments manage high sample volumes under strict turnaround times, with vendor lock-in and fragmented software as major obstacles to scaling their digital pathology workflows. Last June, at the European Congress of Digital Pathology [...]

Unlocking Diagnostic Value at Fimlab with Aiforia® Breast Cancer Suite2026-08-03T12:39:34+00:00

Clinisys Partners with Decisions to Bring Low-Code / No-Code LIMS/LIS Configuration to Laboratory Environments

2026-08-10T07:55:31+00:00

New strategic collaboration introduces a scalable alternative to traditional LIMS / LIS configuration models—empowering laboratories to accelerate time-to-value while maintaining operational control and regulatory confidence.  Clinisys, a global provider of laboratory informatics solutions, today announced a strategic partnership with Decisions, an enterprise low-code and no-code (LCNC) orchestration and automation platform. Together, the companies will deliver [...]

Clinisys Partners with Decisions to Bring Low-Code / No-Code LIMS/LIS Configuration to Laboratory Environments2026-08-10T07:55:31+00:00

Aiforia Lands EU Financing to Develop AI-powered Cancer Detection

2026-08-03T12:15:42+00:00

EIB provides €20 million venture debt financing to Finnish life-science company Aiforia, to further develop its AI powered platform used in digital tissue analysis. Supported under the European Commission’s InvestEU programme, the financing will accelerate Aiforia’s product development and boost its commercial operations. Aiforia’s deep learning artificial intelligence (AI) solutions can revolutionise diagnostic capabilities in image analysis, [...]

Aiforia Lands EU Financing to Develop AI-powered Cancer Detection2026-08-03T12:15:42+00:00

Integrated Mass Spectrometry Technique Reveals Single-Cell Metabolic Fingerprints in Tissue

2026-07-30T13:54:56+00:00

by Christos Evangelou, MSc, PhD – Medical Writer and Editor  Researchers at the University of Münster and Bruker Daltonics GmbH & Co. KG in Germany developed a novel imaging technique that combines mass spectrometry with integrated microscopy to study cellular behavior at the molecular level. The method can map lipids and metabolites within individual cells in intact tissue, providing spatial metabolic insights at the single-cell level. According to the authors, this method can [...]

Integrated Mass Spectrometry Technique Reveals Single-Cell Metabolic Fingerprints in Tissue2026-07-30T13:54:56+00:00

July 2026

Clinisys India has been recognized as the “Best Agile & Scalable GCC Transformation” at the Global Capability Centre Confex & Awards 2026

2026-08-10T13:12:19+00:00

Clinisys India has been recognized as the “Best Agile & Scalable GCC Transformation” at the Global Capability Centre Confex & Awards 2026, which is a premier event focused on the evolution of Global Capability Centers (GCCs) and their role in driving innovation, efficiency, and growth. With a strong emphasis on the integration of advanced technologies such [...]

Clinisys India has been recognized as the “Best Agile & Scalable GCC Transformation” at the Global Capability Centre Confex & Awards 20262026-08-10T13:12:19+00:00

Indica Labs Introduces the HALO® ADC Target Scoring Module, Advancing Antibody-Drug Conjugate Development

2026-07-30T14:25:50+00:00

Indica Labs today announces the launch of the ADC Target Scoring module for the HALO® image analysis platform, a powerful new functionality that supports the development of next-generation precision oncology therapies through quantitative target scoring and spatial analysis. Antibody-drug conjugates (ADC) have emerged as one of the most promising classes of precision oncology therapeutics, combining targeted delivery with the [...]

Indica Labs Introduces the HALO® ADC Target Scoring Module, Advancing Antibody-Drug Conjugate Development2026-07-30T14:25:50+00:00
Go to Top